StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Biotechnology — Tây Âu (Western Europe) by Year

Biotechnology — Tây Âu (Western Europe) ($M)

Danaher Biotechnology — Tây Âu (Western Europe): $2,558M in FY2025, up 11.4% from a year earlier.

Latest, FY2025
2,558
Period ended Dec 31, 2025
Change on a year earlier
+11.4%
2,296 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below

Where the FY2025 figure comes from

Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗

2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiotechnology — Tây Âu (Western Europe) ($M)Year on yearSource
FY2025Dec 31, 20252,558+11.4%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
FY2024Dec 31, 20242,296-4.6%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
FY2023Dec 31, 20232,407-9.0%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
FY2022Dec 31, 20222,645+5.9%Danaher SEC 10-K (FY2024, filed 2025-02-20) ↗
FY2021Dec 31, 20212,497–Danaher SEC 10-K (FY2023, filed 2024-02-21) ↗

Cite this data

StockData. (2026). Danaher Biotechnology — Tây Âu (Western Europe) ($M), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-biotech-geo-we

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.